Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Cash from Investing Activities came in at $9.7 million in Q3 2025, up 2069.92% year-over-year from $446652.7 in Q3 2024, and down 34.6% quarter-over-quarter from $14.8 million in Q2 2025.
Analysis
Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Cash from Investing Activities for 6 consecutive years, with $9.7 million the latest figure, recorded in Q3 2025.
- On a quarterly basis, Cash from Investing Activities rose 2069.92% year-over-year to $9.7 million in Q3 2025; TTM through Sep 2025 was $43.6 million, a 1814.16% increase from a year earlier, with the FY2024 full-year figure at $6.9 million, up 114.99% from the prior year.
- Cash from Investing Activities was $9.7 million for Q3 2025 at Vicarious Surgical, down from $14.8 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $14.8 million in Q2 2025 and troughed at -$43.8 million in Q1 2023.
- A 5-year average of -$865105.3 and a median of -$492000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities plunged 2067.56% in 2023 and surged 3303.47% in 2025, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$867000.0 in 2021, then declined by 14.42% to -$992000.0 in 2022, then jumped by 608.57% to $5.0 million in 2023, then jumped by 186.42% to $14.4 million in 2024, then plunged by 32.93% to $9.7 million in 2025.
- The last three Cash from Investing Activities figures came in at $9.7 million (Q3 2025), $14.8 million (Q2 2025), and $4.6 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 9.69 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | -6.95 Mn |
| Mar 31, 2024 | -144,000.00 |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | -644,000.00 |
| Jun 30, 2023 | -6.36 Mn |
| Mar 31, 2023 | -43.83 Mn |
| Dec 31, 2022 | -992,000.00 |
| Sep 30, 2022 | -782,000.00 |
| Jun 30, 2022 | -1.56 Mn |
| Mar 31, 2022 | -2.02 Mn |
| Dec 31, 2021 | -867,000.00 |
| Sep 30, 2021 | -82,000.00 |
| Jun 30, 2021 | -212,000.00 |
| Mar 31, 2021 | -128,000.00 |
| Dec 31, 2020 | -345.00 Mn |